The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Mark H. Rider sits on this spectrum.
This scientist: 160 publications — 32nd percentile
32% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 1,028 publications or more.
The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Mark H. Rider sits on this spectrum.
This scientist: 62 D-Index — 46th percentile
46% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 167 D-Index or more.
Mark H. Rider is affiliated with the Université Catholique de Louvain in Belgium. Their research work spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a significant focus on Physiology and Molecular Biology as subfields. Their scholarly output includes topics related to Metabolism, Diabetes, and Cancer; Pancreatic function and diabetes; Alzheimer's disease research and treatments; Calcium signaling and nucleotide metabolism; Adipose Tissue and Metabolism; Dementia and Cognitive Impairment Research; and Parkinson's Disease Mechanisms and Treatments.
Their recent publication record features several papers across well-known scientific journals. These include:
Mark H. Rider frequently publishes in several specific venues, notably:
Their collaboration network includes co-authors with whom they have published multiple times, such as:
Their research covers a wide array of topics, with an emphasis on the molecular mechanisms underlying metabolic regulation and neurological diseases. Several of their papers investigate key aspects of AMPK signaling and its roles in metabolism and exercise. Their work on tau protein modifications contributes to the understanding of Alzheimer's disease and other tauopathies, while other studies explore erythrocyte morphology in pathological states.
Overall, Mark H. Rider's body of work contributes to the intersection of metabolism, molecular biology, and disease mechanisms, published across multidisciplinary journals in medicine and biochemistry.
Katrien De Bock;Maria Georgiadou;Sandra Schoors;Anna Kuchnio
A S Marsin;L Bertrand;M H Rider;J Deprez
Johan Deprez;Didier Vertommen;Dario R. Alessi;Louis Hue
Sandrine Horman;Gareth J. Browne;Ulrike Krause;Jigna V. Patel
Louis Hue;Mark Rider
Mark H. Rider;Luc Bertrand;Didier Vertommen;Paul A. Michels
Sandrine Horman;Didier Vertommen;Richard Heath;Dietbert Neumann
Angela Woods;Didier Vertommen;Dietbert Neumann;Roland Türk
Karin Dahan;Olivier Devuyst;Michèle Smaers;Didier Vertommen
Christophe Depré;Mark H. Rider;Louis Hue
Delphine Meisse;Mark Van de Casteele;Christophe Beauloye;Isabelle Hainault
Ghislain Delpierre;Mark H. Rider;Francois Collard;Vincent Stroobant
Sandrine Horman;Christophe Beauloye;Didier Vertommen;Jean-Louis Vanoverschelde
Younes Achouri;Gaëtane Noël;Didier Vertommen;Mark H. Rider
Manuel Johanns;Y.-C. Lai;M.-F. Hsu;R. Jacobs
Sandrine Horman;Nicole Morel;Didier Vertommen;Nusrat Hussain
Younes Achouri;Mark H. Rider;Emile Van Schaftingen;Mariette Robbi
Louis Hue;Christophe Beauloye;Anne-Sophie Marsin;Luc Bertrand
Didier Vertommen;Joris Van Roy;Jean-Pierre Szikora;Mark H. Rider
Ulrike Krause;Mark H. Rider;Louis Hue
If you think any of the details on this page are incorrect, let us know.
Anhui University
Chongqing University
Canon (Japan)
Copenhagen University Hospital
Beihang University
Tufts University
Aix-Marseille University
United States Geological Survey
University of Sheffield
Maastricht University
Wayne State University
University of Warwick
University of Otago
The University of Texas MD Anderson Cancer Center
University of Michigan–Ann Arbor
Fudan University
